Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoSCOPE: Pre-operative Chemoradiotherapy for Resectable Oesophageal Cancer
NCT01843829Phase 2Unknown
- Start
- Oct 2013
- Primary completion
- May 2015
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin, oxaliplatin, capecitabine in esophageal cancer. Status: unknown.
02
Drugs
paclitaxelcarboplatinoxaliplatincapecitabine
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01843829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843829.